A U-shaped association between baseline neutrophil count and COVID-19-related mortality: A retrospective cohort study

被引:8
作者
Fu, Wei [1 ]
Chen, Chi [2 ]
Chen, Xin-Lin [6 ]
Wang, Kun [3 ]
Zuo, Peiyuan [4 ]
Liu, Yuwei [5 ]
Zhang, Meng [3 ]
Zhao, Xiaofang [3 ]
Xie, Songpu [3 ]
Zhang, Hao [3 ]
Geng, Yan [7 ]
Liu, Chengyun [3 ]
机构
[1] 925th Hosp PLA Joint Logist Support Force, Dept Gastroenterol, Guiyang, Peoples R China
[2] GuiZhou Univ Tradit Chinese Med, Dept Immunol & Microbiol, Guiyang, Guizhou, Peoples R China
[3] Empower UX&Y Solut Inc, Dept Epidemiol & Biostat, Boston, MA USA
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Peoples R China
[6] Wuhan Univ, Zhongnan Hosp, Dept Geriatr, Wuhan, Peoples R China
[7] 923th Hosp PLA Joint Logist Support Force, Dept Gastroenterol, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
baseline neutrophil count; change rate; COVID-19-infection; nonlinearity;
D O I
10.1002/jmv.26794
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Several descriptive studies have reported that higher neutrophil count (NC) may be correlated with poor prognosis in patients with confirmed COVID-19 infection. However, the findings from these studies are limited by methodology and data analysis. This study is a cohort study. We nonselectively and consecutively collected a total of 663 participants in a Chinese hospital from January 7 to February 28. Standardized and two-piecewise Cox regression model were employed to evaluate the association between baseline neutrophil count (bNC), neutrophil count change rate (NCR), and death. bNC had a U-shaped association with death. In the range of 0.1 to <= 1.49 x 10(9)/L (hazard ratio [HR] = 0.19, 95% confidence interval [CI] = 0.05-0.66) and >3.55 x 10(9)/L of bNC (HR = 2.82, 95% CI = 1.19-6.67), the trends on bNC with mortality were opposite. By recursive algorithm, the bNC at which the risk of the death was lower in the range of >1.49 to <= 3.55 x 10(9)/L (HR = 13.64, 95% CI = 0.25-74.71). In addition, we find that NCRs (NCR1 and NCR2) are not associated with COVID-19-related deaths. Compared with NCR, bNC has the potential to be used for early risk stratification in patients with COVID-19 infection. The relationship between bNC and mortality was U-shaped. The safe range of bNC was 1.64-4.0 x 10(9)/L. Identifying the correlation may be helpful for early risk stratification and medical decision-making.
引用
收藏
页码:4265 / 4272
页数:8
相关论文
共 21 条
  • [1] Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review
    Adhikari, Sasmita Poudel
    Meng, Sha
    Wu, Yu-Ju
    Mao, Yu-Ping
    Ye, Rui-Xue
    Wang, Qing-Zhi
    Sun, Chang
    Sylvia, Sean
    Rozelle, Scott
    Raat, Hein
    Zhou, Huan
    [J]. INFECTIOUS DISEASES OF POVERTY, 2020, 9 (01)
  • [2] Dong X C, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P638, DOI 10.3760/cma.j.cn112338-20200221-00146
  • [3] Biochemical aspects of coronavirus replication and virus-host interaction
    Enjuanes, Luis
    Almazan, Femando
    Sola, Isabel
    Zuniga, Sonia
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 2006, 60 : 211 - 230
  • [4] A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
    Fung, Sin-Yee
    Yuen, Kit-San
    Ye, Zi-Wei
    Chan, Chi-Ping
    Jin, Dong-Yan
    [J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 558 - 570
  • [5] General Office of National Health Commission of People's Republic of China OoNAoTCM, 2020, CHINAS MED, V15, P801
  • [6] Clinical Characteristics of Coronavirus Disease 2019 in China
    Guan, W.
    Ni, Z.
    Hu, Yu
    Liang, W.
    Ou, C.
    He, J.
    Liu, L.
    Shan, H.
    Lei, C.
    Hui, D. S. C.
    Du, B.
    Li, L.
    Zeng, G.
    Yuen, K. -Y.
    Chen, R.
    Tang, C.
    Wang, T.
    Chen, P.
    Xiang, J.
    Li, S.
    Wang, Jin-lin
    Liang, Z.
    Peng, Y.
    Wei, L.
    Liu, Y.
    Hu, Ya-hua
    Peng, P.
    Wang, Jian-ming
    Liu, J.
    Chen, Z.
    Li, G.
    Zheng, Z.
    Qiu, S.
    Luo, J.
    Ye, C.
    Zhu, S.
    Zhong, N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) : 1708 - 1720
  • [7] New fronts emerge in the influenza cytokine storm
    Guo, Xi-zhi J.
    Thomas, Paul G.
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (05) : 541 - 550
  • [8] The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
    Guo, Yan-Rong
    Cao, Qing-Dong
    Hong, Zhong-Si
    Tan, Yuan-Yang
    Chen, Shou-Deng
    Jin, Hong-Jun
    Tan, Kai-Sen
    Wang, De-Yun
    Yan, Yan
    [J]. MILITARY MEDICAL RESEARCH, 2020, 7 (01)
  • [9] What we know so far: COVID-19 current clinical knowledge and research
    Lake, Mary A.
    [J]. CLINICAL MEDICINE, 2020, 20 (02) : 124 - 127
  • [10] Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children
    Liu, Huanhuan
    Liu, Fang
    Li, Jinning
    Zhang, Tingting
    Wang, Dengbin
    Lan, Weishun
    [J]. JOURNAL OF INFECTION, 2020, 80 (05) : E7 - E13